ScottHuntingtonMDMPH, MSHP

PubMed

• Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Rela...
  Garg, M., Puckett, J., Kamal-Bahl, S., Raut, M., Ryland, K., Doshi, J., Huntington, S.> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 9
• Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia.
  de Nigris, E., Puckett, J., Kamal-Bahl, S., Farooqui, M., Ryland, K., Sarpong, E., Yang, X., Doshi, J., Huntington, S., Leng, S.> ;Cancer Medicine. 2024 Jan 1
• Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
  Jackson T Bowers, Jacob Anna, Steven M Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A Spinner, Shuning Li, Marcus R Mess...> ;Blood Advances. 2023 Nov 14
• Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia.
  Scott F Huntington, Enrico de Nigris, Justin Puckett, Sachin Kamal-Bahl, Mohammed Farooqui, Katherine Ryland, Eric Sarpong, Siyang Leng, Xiaoqin Yang, Jalpa A Doshi> ;Leukemia & Lymphoma. 2023 Dec 1
• Peripheral Blasts in a Patient Receiving Chemotherapy.
  Sabin Kshattry, Terri L Parker, Scott F Huntington> ;JAMA. 2023 Oct 24
• 1 citations
  Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
  Devlin, S., von Keudell, G., Vemuri, S., Shukla, M., Falco, V., Cuello, B., Park, J., Durham, B., Winer, E., Huntington, S., Gore, S., Stone, R., Abdel-Wahab, O., Tall...> ;NEJM Evidence. 2023 Oct 1
• Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia.
  Scott F Huntington, Beenish S Manzoor, Justin T Puckett, Sachin Kamal-Bahl, Hasan Alhasani, Arliene Ravelo, Dureshahwar Jawaid, Jalpa A Doshi> ;Leukemia & Lymphoma. 2023 Dec 1
• 2 citations
  Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.
  Nikolai A Podoltsev, Rong Wang, Rory M Shallis, Jessica M Stempel, Mengyang Di, Natalia Neparidze, Amer M Zeidan, Scott F Huntington, Smith Giri, Sarah C Hull, Steven ...> ;Cancer Medicine. 2023 Sep 1
• 1 citations
  Helicobacter pylori-negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: A clinicopathologic analysis.
  Sean X Gu, Alexa J Siddon, Scott F Huntington, Dhanpat Jain> ;American Journal of Clinical Pathology. 2023 Dec 1
• 1 citations
  Assessing unmet need among elderly Medicare Beneficiaries with Mantle cell lymphoma: an analysis of treatment patterns, survival, healthcare resource utilization, and ...
  Patrick Squires, Justin Puckett, Katherine Elizabeth Ryland, Sachin Kamal-Bahl, Monika Raut, Jalpa A Doshi, Scott F Huntington> ;Leukemia & Lymphoma. 2023 Jul 27
• 1 citations
  Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence.
  Rory M Shallis, Rong Wang, Amer M Zeidan, Scott F Huntington, Natalia Neparidze, Jessica M Stempel, Lourdes M Mendez, Mengyang Di, Xiaomei Ma, Nikolai A Podoltsev> ;Blood Advances. 2023 Jul 11
• 3 citations
  The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021.
  Gaurav Goyal, Krystal W Lau, Xiaoliang Wang, Amy J Davidoff, Scott F Huntington, Omer Jamy, Gregory Calip, Harsh Shah, Deborah M Stephens, Rebecca Miksad, Ravi B Parik...> ;JAMA Network Open. 2023 Jun 1
• 1 citations
  Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?
  Jan Philipp Bewersdorf, Scott F Huntington, Amer M Zeidan> ;Journal of the National Comprehensive Cancer Network. 2023 Apr 10
• 2 citations
  Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea.
  Rong Wang, Rory M Shallis, Jessica M Stempel, Scott F Huntington, Amer M Zeidan, Steven D Gore, Xiaomei Ma, Nikolai A Podoltsev> ;Blood Advances. 2023 Mar 14
• Functional status and therapy for older adults with diffuse large B-cell lymphoma in nursing homes: A population-based study.
  Mengyang Di, Tamra Keeney, Emmanuelle Belanger, Scott F Huntington, Adam J Olszewski, Orestis A Panagiotou> ;Journal of the American Geriatrics Society. 2023 Jul 1
• 2 citations
  DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, m...
  Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqba...> ;American Journal of Hematology. 2023 May 1
• 1 citations
  Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with-mutant acute myeloid leukemia.
  Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory M Shallis, Nikolai A Podoltsev, Maximilian Stahl, Eytan M Stein, Scott F Huntington, Amer M Zeidan> ;Leukemia & Lymphoma. 2023 Feb 1
• 2 citations
  Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis.
  Mengyang Di, Jessica B Long, Shalin K Kothari, Tarsheen Sethi, Amer M Zeidan, Nikolai A Podoltsev, Rory M Shallis, Rong Wang, Xiaomei Ma, Scott F Huntington> ;Haematologica. 2023 Aug 1
• 4 citations
  Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period.
  Natalia Neparidze, Rong Wang, Amer M Zeidan, Nikolai A Podoltsev, Rory M Shallis, Xiaomei Ma, Amy J Davidoff, Scott F Huntington> ;Leukemia. 2022 Aug 1
• When competition is not enough: leveraging US policies to curb oral anticancer drug costs.
  Scott F Huntington, Potnis, K.> ;The Lancet. Oncology. 2022 Jul 1
• 6 citations
  Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis.
  Mengyang Di, Can Cui, Shalin K Kothari, Amer M Zeidan, Nikolai A Podoltsev, Natalia Neparidze, Rory M Shallis, Rong Wang, Xiaomei Ma, Scott F Huntington> ;Blood Advances. 2022 Jun 14
• 5 citations
  Barriers and solutions to improve access for chimeric antigen receptor therapies.
  Sachin Kamal-Bahl, Justin T Puckett, Indranil Bagchi, Ellen Miller-Sonet, Scott F Huntington> ;Immunotherapy. 2022 May 27
• Peripheral Blood Involvement at Staging in Patients With Aggressive Peripheral T-Cell Lymphoma.
  Jonathan Avery, Namrata Chandhok, Chanelle Rainey, Richard Torres, Scott Huntington, Iris Isufi, Stuart Seropian, Mina L Xu, Francine Foss> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Sep 1
• 5 citations
  Cost-effectiveness analysis of oral azacitidine maintenance therapy in acute myeloid leukemia.
  Jan Philipp Bewersdorf, Kishan Patel, Scott F. Huntington, Amer M. Zeidan> ;Blood Advances. 2021 Nov 23
• 5 citations
  Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia in the United States.
  Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A. Podoltsev, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Rong Wang, Amer M. Zeidan, Amy J. Davidoff> ;Blood Advances. 2021 Nov 1
• Join now to see all

Abstracts/Posters

• A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalid...
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Evaluation of Efficacy and Safety of Front-Line Regimens for the Treatment of Transplant Ineligible Patients with Multiple Myeloma: A Network Meta-Analysis of Phase 2/...
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Peripheral Blood Involvement By Flow Cytometry As a Prognostic Factor in Aggressive T Cell Lymphomas Following Autologous Stem Cell Transplantation
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United State...
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Populati...
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Impact of the 2011 European Leukemianet (ELN) Guidelines for Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms on Therapeutic Phlebotomy and ...
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Effectiveness of Hypomethylating Agents (HMAs) and Lenalidomide (Len) in Older Patients (pts) with Refractory Anemia with Ring Sideroblasts: A Large Populatio...
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neopl...
  Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Hodgkin Lymphoma: Celebrating 200 Years Since Thomas Hodgkin Entered Medicine 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Cost-effectiveness analysis of brentuximab vedotin with chemotherapy in newly diagnosed stage III/IV Hodgkin lymphoma. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018